Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis

20216 citationsJournal Articlegold Open Access

Authors

RCI is a cost-effective alternative treatment for MS relapses compared to PMP and IVIg from the US payer and societal perspectives.

Published in: ClinicoEconomics and Outcomes Research

Volume Volume 13, pp. 883-892

Field-Weighted Citation Impact: 0.45